Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis A Brito

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|June 25, 2010
Acceptable levels of endotoxin in vaccine formulations during preclinical researchLuis A Brito, Manmohan Singh
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 8, 2014
Designing and building the next generation of improved vaccine adjuvantsLuis A Brito, Derek T O'Hagan
Seminars in Immunology|July 16, 2013
Vaccine adjuvant formulations: a pharmaceutical perspectiveLuis A Brito, Padma Malyala, Derek T O'Hagan
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Overview of Vaccine Adjuvants: Introduction, History, and Current StatusRuchi R Shah, Kimberly J Hassett, Luis A Brito
Journal of Biomedical Materials Research. Part A|July 2, 2009
In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stentsLuis A Brito, Saradha Chandrasekhar, Steven R Little, et al.
Biomedical Engineering Online|September 30, 2010
Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosisLuis A Brito, Saradha Chandrasekhar, Steven R Little, et al.
Nanomedicine (London, England)|December 23, 2014
The impact of size on particulate vaccine adjuvantsRuchi R Shah, Derek T O'Hagan, Mansoor M Amiji, et al.
Expert Opinion on Drug Delivery|March 27, 2014
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccinesRaquel P Deering, Sushma Kommareddy, Jeffrey B Ulmer, et al.
Vaccine|July 5, 2011
An alternative renewable source of squalene for use in emulsion adjuvantsLuis A Brito, Michelle Chan, Barbara Baudner, et al.
Cell|March 19, 2021
Novel approaches for vaccine developmentMakda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|June 25, 2010
Acceptable levels of endotoxin in vaccine formulations during preclinical researchLuis A Brito, Manmohan Singh
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 8, 2014
Designing and building the next generation of improved vaccine adjuvantsLuis A Brito, Derek T O'Hagan
Seminars in Immunology|July 16, 2013
Vaccine adjuvant formulations: a pharmaceutical perspectiveLuis A Brito, Padma Malyala, Derek T O'Hagan
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Overview of Vaccine Adjuvants: Introduction, History, and Current StatusRuchi R Shah, Kimberly J Hassett, Luis A Brito
Journal of Biomedical Materials Research. Part A|July 2, 2009
In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stentsLuis A Brito, Saradha Chandrasekhar, Steven R Little, et al.
Biomedical Engineering Online|September 30, 2010
Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosisLuis A Brito, Saradha Chandrasekhar, Steven R Little, et al.
Nanomedicine (London, England)|December 23, 2014
The impact of size on particulate vaccine adjuvantsRuchi R Shah, Derek T O'Hagan, Mansoor M Amiji, et al.
Expert Opinion on Drug Delivery|March 27, 2014
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccinesRaquel P Deering, Sushma Kommareddy, Jeffrey B Ulmer, et al.
Vaccine|July 5, 2011
An alternative renewable source of squalene for use in emulsion adjuvantsLuis A Brito, Michelle Chan, Barbara Baudner, et al.
Cell|March 19, 2021
Novel approaches for vaccine developmentMakda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Pageof 3